Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB04868_nanopub.RAmVWZg941w85UI2aJNq-ENkXeB4S8VEFG7Uxjz3oihKo#assertion>. }
Showing items 1 to 19 of
19
with 100 items per page.
- drugbank:DB04868 type drugbank_vocabulary:Drug assertion.
- drugbank:DB04868 label "Nilotinib [drugbank:DB04868]" assertion.
- drugbank:DB04868 seeAlso DB04868 assertion.
- drugbank:DB04868 identifier "drugbank:DB04868" assertion.
- drugbank:DB04868 description "Nilotinib, also known as AMN107, is a tyrosine kinase inhibitor under investigation as a possible treatment for chronic myelogenous leukemia (CML). In June 2006, a Phase I clinical trial found nilotinib has a relatively favorable safety profile and shows activity in cases of CML resistant to treatment with imatinib (Gleevec®), another tyrosine kinase inhibitor currently used as a first-line treatment. [Wikipedia]" assertion.
- drugbank:DB04868 title "Nilotinib" assertion.
- drugbank:DB04868 bio2rdf_vocabulary:identifier "DB04868" assertion.
- drugbank:DB04868 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB04868 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB04868" assertion.
- drugbank:DB04868 bio2rdf_vocabulary:x-identifiers.org DB04868 assertion.
- drugbank:DB04868 drugbank_vocabulary:drugbank-id "DB04868" assertion.
- drugbank:DB04868 drugbank_vocabulary:x-cas cas:641571-10-0 assertion.
- drugbank:DB04868 drugbank_vocabulary:x-chemspider chemspider:559260 assertion.
- drugbank:DB04868 drugbank_vocabulary:x-pubchemcompound pubchem.compound:644241 assertion.
- drugbank:DB04868 drugbank_vocabulary:x-pubchemsubstance pubchem.substance:99443226 assertion.
- drugbank:DB04868 drugbank_vocabulary:x-atc atc:L01XE08 assertion.
- drugbank:DB04868 drugbank_vocabulary:x-chebi chebi:52172 assertion.
- drugbank:DB04868 drugbank_vocabulary:x-pharmgkb pharmgkb:PA165958345 assertion.
- drugbank:DB04868 drugbank_vocabulary:x-wikipedia wikipedia:Nilotinib assertion.